Day: March 27, 2020

CHICAGO, March 27, 2020 (GLOBE NEWSWIRE) — Six in 10 Americans (59%) said their household income has been negatively impacted by the COVID-19 pandemic – an increase of 53% from those who reported impact the previous week. An additional 10% of U.S. adults said they expect their household income will suffer in the future. The newly released research from TransUnion (NYSE: TRU) found that consumers from the youngest generations, as well as those persons least informed about their credit, perceive the greatest financial hardship.TransUnion has initiated a survey of adults in the U.S. and abroad to better understand the financial impact of COVID-19 on consumers. This week’s U.S. survey of more than 3,100 adults marked the second in the ongoing research. Additional details as well as resources for consumers looking to minimize the potential...

Holbrook, NY, March 27, 2020 (GLOBE NEWSWIRE) — Emerald Organic Products, Inc. (OTC: EMOR) (“Emerald”, “Emerald Organic”, or “Emerald Organic Products”) a diversified health sciences company, today announced it has signed a Plan of Merger Agreement with Bonsa Health, a leading digital pharmacy capable of same day delivery of Rx medications anywhere in the United States. Under the terms of the acquisition, Emerald will take a 51% controlling stake in Bonsa in an all stock transaction. In the age of technological advances and need for modern convenience, Bonsa offers an all encompassing tech-driven digital solution that creates an effective, secured communication line between providers, patients, and pharmacists to expedite prescription fulfillment and same day delivery. Bonsa is expecting to enhance...

Hermed offentliggøres ajourført dokument med § 62-oplysninger til foreningens investorer fsva. andelsklassen European CLO Investment Grade DKK og og afdelingen European CLO Opportunity KL.Dokumentet er ajourført med regnskabstal fra årsrapporten for 2019.Kontaktperson(er):Direktør Caspar Møller, tlf. +45 3332 7070.Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia.com.Attachment§62-dok – EuroCLO.IG.EUR & OPP – AccInvKF – mar’20

Please read the full announcement in PDFAttachment2020_20_Reduction_of_shares_capital_EN

Læs venligst hele meddelelsen i PDF formatVedhæftet fil2020_20_Reduction_of_shares_capital_DA

– Enhances Triferic platform by providing patients with greater access to Rockwell Medical’s innovative therapeutic by expanding administration options for clinicians –– Major milestone supports the potential for expanding global adoption of Triferic and transforming the standard of care for anemia management in hemodialysis patients –WIXOM, Mich., March 27, 2020 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that the U.S. Food and Drug Administration (“FDA”) has approved its New Drug Application (“NDA”) for its intravenous formulation of Triferic, Triferic AVNU. With this approval, Triferic AVNU joins Triferic Dialysate as the only FDA-approved...

Reference is made to the stock exchange announcement from Grieg Seafood ASA (the “Company”) released on 7 February 2020 regarding the acquisition of Grieg Newfoundland AS (the “Transaction”). In connection with the transaction, the board of the Company has on 27 March 2020 resolved to complete a directed private placement by issuing 1,785,042 new shares (the “New Shares”) in the Company to Grieg Aqua AS, Kvasshøgdi AS, Knut Skeidsvoll and ‪10546569 Canada Inc (the “Private Placement”) as part of consideration for the shares in Grieg Newfoundland AS. The subscription price for each New Share will be NOK ‪140.052727, corresponding to a total contribution in kind of NOK 250,000,000. The New Shares shall be subscribed on closing of the Transaction which shall occur on 31 March 2020 at the latest.The...

Keskisuomalainen Oyj:n vuosikertomus vuodelta 2019 on julkaistuKeskisuomalainen Oyj, pörssitiedote, 27.3.2020 klo 17.10Keskisuomalainen Oyj:n suomenkielinen vuosikertomus vuodelta 2019 on julkaistu.Sähköinen vuosikertomus vuodelta 2019 on julkaistu yhtiön kotisivuilla osoitteessa www.keskisuomalainen.com kohdassa Sijoittajalle.Painetun vuosikertomuksen voi tilata yhtiöltä: Tiina Happonen, talouspäällikkö, Keskisuomalainen Oyj, tiina.happonen@keskisuomalainen.fi.Lisätietoja: Vesa-Pekka Kangaskorpi, toimitusjohtaja, Keskisuomalainen Oyj, p. 050 688 33Keskisuomalainen OyjVesa-Pekka Kangaskorpitoimitusjohtajawww.keskisuomalainen.comLiiteVuosikertomus_2019_Keskisuomalainen Oyj

SUWANEE, GA, March 27, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Tuesday, March 31, 2020, beginning at 9AM Eastern Time to discuss the 2019 financial results, provide a business update and answer questions. Shareholders and other interested parties can participate in the conference call by dialing 844-369-8770 (U.S.) or 862-298-0840 (international) or via webcast at https://www.webcaster4.com/Webcast/Page/2249/33910. A replay of the conference call will be available beginning two hours after its completion through April 7, 2020, by dialing 877-481-4010 (U.S.) or 919-882-2331 and entering replay passcode 33910 and a replay of the webcast will be available at https://www.webcaster4.com/Webcast/Page/2249/33910 until July 1, 2020.About...